Omkar Speciality Chemicals Limited (BOM:533317)
India · Delayed Price · Currency is INR 5.25
+0.07 (1.35%)
At close: Feb 13, 2026
BOM:533317 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 |
Operating Revenue | 193.58 | 229.83 | 451.25 | 568.77 | 426.52 | 1,916 |
Revenue | 193.58 | 229.83 | 451.25 | 568.77 | 426.52 | 1,916 |
Revenue Growth (YoY) | -59.12% | -49.07% | -20.66% | 33.35% | -77.74% | -39.51% |
Cost of Revenue | 137.05 | 167 | 276.75 | 444.3 | 288.84 | 2,060 |
Gross Profit | 56.53 | 62.82 | 174.5 | 124.47 | 137.68 | -143.71 |
Selling, General & Admin | 27.63 | 29.02 | 27.26 | 36.55 | 45.62 | 41.48 |
Other Operating Expenses | 80.84 | 81.27 | 66.39 | 85.21 | 100.24 | 248.43 |
Operating Expenses | 125.48 | 128.16 | 129.24 | 187.63 | 225.75 | 371.49 |
Operating Income | -68.95 | -65.34 | 45.26 | -63.16 | -88.07 | -515.2 |
Interest Expense | -63.27 | -60.71 | -55.02 | -49.26 | -145.28 | -240.66 |
Interest & Investment Income | - | - | 1.14 | 0.1 | 0.22 | 3.55 |
Currency Exchange Gain (Loss) | - | - | 0.32 | -2.45 | 2.4 | 8.15 |
Other Non Operating Income (Expenses) | - | - | -0.65 | 1.09 | 5.87 | -9.24 |
EBT Excluding Unusual Items | -132.23 | -126.05 | -8.95 | -113.67 | -224.85 | -753.39 |
Gain (Loss) on Sale of Investments | - | - | - | - | 10.29 | 11.73 |
Gain (Loss) on Sale of Assets | - | - | - | 0.57 | 0.05 | 2.04 |
Asset Writedown | - | - | - | - | 99.3 | -525.86 |
Other Unusual Items | - | - | 40.45 | - | - | - |
Pretax Income | -132.23 | -126.05 | 31.49 | -113.1 | -115.21 | -1,265 |
Income Tax Expense | - | - | 11.36 | 33.23 | 53.54 | -225.8 |
Earnings From Continuing Operations | -132.23 | -126.05 | 20.14 | -146.33 | -168.75 | -1,040 |
Net Income | -132.23 | -126.05 | 20.14 | -146.33 | -168.75 | -1,040 |
Preferred Dividends & Other Adjustments | - | - | - | 0.03 | - | - |
Net Income to Common | -132.23 | -126.05 | 20.14 | -146.36 | -168.75 | -1,040 |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Change (YoY) | 0.13% | -0.07% | - | - | - | - |
EPS (Basic) | -6.43 | -6.13 | 0.98 | -7.11 | -8.20 | -50.52 |
EPS (Diluted) | -6.43 | -6.13 | 0.98 | -7.11 | -8.20 | -50.52 |
Free Cash Flow | - | 8.92 | -164.22 | 39.88 | 11.46 | -283.62 |
Free Cash Flow Per Share | - | 0.43 | -7.98 | 1.94 | 0.56 | -13.78 |
Gross Margin | 29.20% | 27.33% | 38.67% | 21.88% | 32.28% | -7.50% |
Operating Margin | -35.62% | -28.43% | 10.03% | -11.10% | -20.65% | -26.89% |
Profit Margin | -68.31% | -54.85% | 4.46% | -25.73% | -39.56% | -54.27% |
Free Cash Flow Margin | - | 3.88% | -36.39% | 7.01% | 2.69% | -14.80% |
EBITDA | -55.5 | -47.46 | 80.82 | 2.15 | -8.53 | -433.88 |
EBITDA Margin | -28.67% | -20.65% | 17.91% | 0.38% | -2.00% | -22.65% |
D&A For EBITDA | 13.46 | 17.88 | 35.57 | 65.31 | 79.54 | 81.32 |
EBIT | -68.95 | -65.34 | 45.26 | -63.16 | -88.07 | -515.2 |
EBIT Margin | -35.62% | -28.43% | 10.03% | -11.10% | -20.65% | -26.89% |
Effective Tax Rate | - | - | 36.06% | - | - | - |
Revenue as Reported | 204.26 | 239.46 | 459.85 | 573.25 | 451.13 | 2,013 |
Advertising Expenses | - | - | 0.45 | 0.51 | 1.78 | 2.25 |
Updated Aug 13, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.